$0.25
Market Cap
$102.00M
Shares Outstanding
400.6M
Primary Exchange
XNAS
Currency
USD
Type
CS
IPO Date
Jan 12, 2021
Round Lot
100
Locale
US
Day Open
$0.26
Day High
$0.29
Day Low
$0.25
Volume
51.6K
VWAP
$0.25
Prev Close
$0.25
Transactions
--
Acc. Volume
--
BGM Group Ltd is a biopharmaceuticals, bio-extraction, and medical health business. Its product range includes oxytetracycline APIs, licorice preparations, and crude heparin sodium. Maximum revenue is from Oxytetracycline & Licorice and TCMD, followed by Heparin products and Sausage casing.
BGM Group Ltd. Class A Ordinary Shares (BGM) closed the 2026-09-15 session at $0.25, down 2.91% versus the previous close (-0.01). The stock opened at $0.26 and traded between $0.25 and $0.29 during that session. Session trading volume was 52K shares. The volume-weighted average price (VWAP) is $0.25.
BGM Group Ltd is a biopharmaceuticals, bio-extraction, and medical health business. Its product range includes oxytetracycline APIs, licorice preparations, and crude heparin sodium. Maximum revenue is from Oxytetracycline & Licorice and TCMD, followed by Heparin products and Sausage casing.
BGM Group Ltd. Class A Ordinary Shares has a market capitalization of $102.0 million. BGM is listed on the XNAS exchange. The company employs approximately 471 people. The recorded listing date is 2021-01-12.
On this page you can find market BGM stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors.